<p>This study cohort was collected as part of the National Institute of Mental Health (NIMH) Alzheimer's disease Genetics Initiative Study. Recruitment of families, predominantly sibling, for the cohort was focused on local memory disorder clinics, nursing homes, and the surrounding community. Clinical evaluation was performed at the University of Alabama at Birmingham, Johns Hopkins University, and Massachusetts General Hospital/Harvard Medical School. Informed consent was obtained from all study participants, for participants with extensive cognitive impairment, a legal guardian or caregiver with power of attorney provided consent. To determine age of onset, a creditable informer was interviewed and medical records were evaluated.</p>

Massachusetts General Hospital/Eisai National Institute of Mental Health    (NIMH) Genetics Initiative Alzheimer's Disease GWAS - Affymetrix    GeneChip Human Mapping 500K Array Set

Massachusetts General Hospital/Eisai National Institute of Mental Health (NIMH) Genetics Initiative Alzheimer's Disease GWAS - Affymetrix GeneChip Human Mapping 500K Array Set

ApoE-4 and Age at Onset of Alzheimer's Disease

Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.